{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:24:18Z","timestamp":1761823458809},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.anndiagpath.2011.11.003","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T03:18:39Z","timestamp":1332472719000},"page":"255-259","source":"Crossref","is-referenced-by-count":17,"title":["Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma"],"prefix":"10.1016","volume":"16","author":[{"given":"Aditya","family":"Raghunathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Olar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Coventry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Debski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance T.","family":"Albarracin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth D.","family":"Aldape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Daniel P.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne Z.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory N.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00295665","article-title":"Probable assignment of soluble isocitrate dehydrogenase (IDH1) to 2q33.3","volume":"71","author":"Narahara","year":"1985","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/j.anndiagpath.2011.11.003_bb0010","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.2353\/ajpath.2010.100680","article-title":"Molecular classification of low-grade diffuse gliomas","volume":"177","author":"Kim","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/humu.20937","article-title":"IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors","volume":"30","author":"Bleeker","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0025","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","article-title":"Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas","volume":"118","author":"Hartmann","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-010-0645-6","article-title":"The prognostic IDH1R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma","volume":"119","author":"Bleeker","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"7274","key":"10.1016\/j.anndiagpath.2011.11.003_bb0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.anndiagpath.2011.11.003_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2010.05.115","article-title":"Glioma-derived mutations in IDH: from mechanism to potential therapy","volume":"397","author":"Fu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0055","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1038\/onc.2010.444","article-title":"Cancer-associated IDH mutations: biomarker and therapeutic opportunities","volume":"29","author":"Yen","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/djq262","article-title":"Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia","volume":"102","author":"Garber","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.anndiagpath.2011.11.003_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1470-2045(10)70053-X","article-title":"Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?","volume":"12","author":"Kloosterhof","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ccr.2010.02.024","article-title":"IDH1 and IDH2: not your typical oncogenes","volume":"17","author":"Reitman","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0075","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/djq187","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism","volume":"102","author":"Reitman","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0080","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1158\/0008-5472.CAN-09-2650","article-title":"Mutant metabolic enzymes are at the origin of gliomas","volume":"69","author":"Yan","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-008-0455-2","article-title":"Analysis of the IDH1 codon 132 mutation in brain tumors","volume":"116","author":"Balss","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2011.11.003_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00401-010-0770-2","article-title":"Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology","volume":"121","author":"Capper","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1215\/15228517-2009-025","article-title":"IDH1 mutations are present in the majority of common adult gliomas but are rare in primary glioblastomas","volume":"11","author":"Ichimura","year":"2009","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0100","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","article-title":"Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas","volume":"27","author":"Sanson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00401-010-0701-2","article-title":"Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence of molecular subtypes","volume":"120","author":"Seiz","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","article-title":"IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas","volume":"174","author":"Watanabe","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0115","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/WNL.0b013e3181c34ace","article-title":"IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide","volume":"73","author":"Dubbink","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0120","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00401-010-0781-z","article-title":"Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas","volume":"120","author":"Hartmann","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0125","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1158\/1078-0432.CCR-09-0715","article-title":"IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas","volume":"15","author":"Nobusawa","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1750-3639.2009.00327.x","article-title":"PCR- and restriction endonuclease\u2013based detection of IDH1 mutations","volume":"20","author":"Meyer","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-3639.2009.00352.x","article-title":"Characterization of R132H mutation\u2013specific IDH1 antibody binding in brain tumors","volume":"20","author":"Capper","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-009-0595-z","article-title":"Monoclonal antibody specific for IDH1 R132H mutation","volume":"118","author":"Capper","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1750-3639.2005.tb00112.x","article-title":"Angiocentric neuroepithelial tumor (ANET): a new epilepsy-related clinicopathological entity with distinctive MRI","volume":"15","author":"Lellouch-Tubiana","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/01.jnen.0000182981.02355.10","article-title":"Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma","volume":"64","author":"Wang","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0155","series-title":"(2007) WHO classification of tumors of the central nervous system","first-page":"92","article-title":"Angiocentric glioma","author":"Burger","year":"2007"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1789.2007.00831.x","article-title":"Cortical ependymoma or monomorphous angiocentric glioma","volume":"28","author":"Lum","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0165","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/PAS.0b013e31804a7ebb","article-title":"Angiocentric glioma report of clinico-pathologic and genetic findings in 8 cases","volume":"31","author":"Preusser","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3171\/2008.11.PEDS0858","article-title":"Angiocentric glioma: a case series","volume":"3","author":"Shakur","year":"2009","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.24379","article-title":"Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers","volume":"125","author":"Kang","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0180","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1309\/AJCPD7NR2RMNQDVF","article-title":"Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features","volume":"135","author":"Patel","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0190","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1182\/blood-2010-02-267955","article-title":"IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status","volume":"116","author":"Schnittger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0195","doi-asserted-by":"crossref","first-page":"E1186","DOI":"10.1002\/humu.21201","article-title":"Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma","volume":"31","author":"Gravendeel","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0200","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"Paugh","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2011.11.003_bb0205","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1200\/JCO.2009.23.0805","article-title":"Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network","volume":"27","author":"Weller","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913411001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913411001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T20:20:32Z","timestamp":1543090832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913411001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1092913411001754"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2011.11.003","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}